Anti-doping agencies get help from drug manufacturers

Nowadays numerous pharmaceutical companies are ready to collaborate with anti-doping officials in their fight against application of forbidden products in sports. It sounds strange but this is the reality. In fact, if you look at the fate of EPO, you can understand why drug manufacturers agree to support efforts of anti-doping officials. EPO is really an efficacious remedy for treatment of anemia. Numerous persons with anemia that have used EPO have been treated. But what do you think while hearing about this drug? Almost each individual associates this remedy only with doping in sports. This product has been abused by the American cyclist Lance Armstrong that has cheated the whole world. So, EPO is associated only with cheating, disgrace, etc. Looking at this condition, pharmaceutical companies try to “defend” their medicines from the similar fate. That’s why they cooperate with anti-doping officers.
However several drug manufacturers began to cooperate with anti-doping agencies earlier, sometimes there were some problems between them. Anti-doping officers criticized some pharmaceutical companies for their connections with doping.
Nowadays relations between anti-doping officials and pharmaceutical companies are closer. Pharmaceutical companies share detailed information about new drugs with anti-doping officers. It is precious information for development of detection tests for these medications. While anti-doping agencies learn how preparations are manufactured, how they pass into body, how they work in the body, they can introduce more effectual tests for these drugs.
For example, the pharmaceutical company Roche that introduced the preparation CERA helped anti-doping agencies to elaborate a detection test for it. Later other companies followed the example of Roche. The drug manufacturer GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping agencies and big drug manufacturers become closer, smaller drug manufacturers started to collaborate with anti-doping officials too. While previously pharmaceutical companies haven’t desired to discuss about their relations with anti-doping officials publicly, today they don’t fear to announce about this aspect.